Imatinib mesilate for the treatment of gastrointestinal stromal tumour-Reference-Cited by-同舟云学术

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

Published:2008-04-21 Issue:7 Volume:9 Page:1211-1222
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Cassier Philippe A,Dufresne Armelle,Arifi Samia,Sayadi Hiba El,Labidi Intidar,Ray-Coquard Isabelle,Tabone Séverine,Méeus Pierre,Ranchère Dominique,Sunyach Marie-Pierre,Decouvelaere Anne-Valérie,Alberti Laurent,Blay Jean-Yves

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.9.7.1211

Reference79 articles.

1. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain

2. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

3. Two Hundred Gastrointestinal Stromal Tumors

4. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalised pharmacotherapy options for soft tissue sarcomas;Expert Review of Precision Medicine and Drug Development;2022-01-02

2. Gastrointestinal stromal tumors: Treatment patterns of a population-based sample;Journal of Surgical Oncology;2015-04-21

3. Clinical Pharmacology in Pediatrics;Cancer Drug Discovery and Development;2013-11-30

4. Management of Gastrointestinal Stromal Tumors: Looking Beyond the Knife. An Update on the Role of Adjuvant and Neoadjuvant Imatinib Therapy;Journal of Gastrointestinal Cancer;2012-07-31

5. Dual Energy CT for Monitoring Targeted Therapies in Patients with Advanced Gastrointestinal Stromal Tumor: Initial Results;Current Pharmaceutical Biotechnology;2011-04-01